Invima, Colombia's National Institute of Food and Drug Surveillance, has issued a health alert about the children's supplement 'Hansure Kids', which is being sold in the country without the required sanitary registration. Both opposition and government-aligned outlets report that the product is considered fraudulent because it uses a false or invalid sanitary registration number and is linked to a laboratory that does not appear in official records, meaning its origin, ingredients, and manufacturing conditions are unknown and unverified. Coverage agrees that Invima has asked parents and caregivers to immediately stop using the product if children are currently consuming it, and to avoid purchasing it altogether due to the risk of adverse health effects. Reports also coincide in noting that the alert focuses on the product's unauthorized status, its misleading labeling, and the broad category of risks associated with consuming unregistered health or nutritional products in minors.

Both sides highlight that Invima is the competent authority responsible for monitoring food and supplement safety in Colombia and that it routinely issues health alerts when it detects irregular or illegal products. They also agree that unauthorized children's supplements can pose particular dangers because minors are more vulnerable to unknown concentrations of active substances, contaminants, or poor manufacturing practices. The shared context emphasizes that Colombian regulations require a valid sanitary registration number, traceable manufacturing facilities, and proper labeling before a product can be legally marketed, especially for children. Coverage converges on the idea that this case illustrates broader challenges in controlling informal or fraudulent markets for health-related products and reinforces the importance of checking Invima's official channels to verify whether a supplement is duly authorized.

Areas of disagreement

Responsibility and blame. Opposition-aligned outlets frame the alert as evidence of regulatory gaps and weak enforcement, implying that Invima and the broader health authorities reacted only after the product was already circulating among children. They tend to stress the failure to detect the false registration and unregistered laboratory earlier, using the case to question the government's overall control of the health products market. Government-aligned coverage, by contrast, highlights Invima's rapid response and technical role, portraying the alert as proof that surveillance systems are functioning and capable of intercepting fraudulent products before they cause widespread harm.

Tone toward institutions. Opposition reporting often adopts a skeptical tone toward Invima and the government, underscoring institutional shortcomings and suggesting that similar unauthorized products may be widespread due to systemic negligence. It may hint that parents are left to navigate an under-regulated market with little preventive oversight. Government-aligned outlets present Invima in a more neutral or positive light, focusing on its authority, procedures, and public guidance, and framing the incident as a routine but necessary intervention within an overall functioning regulatory framework.

Framing of public risk. Opposition sources emphasize the potential seriousness of exposing children to unknown substances, using the case to warn about broader public health vulnerabilities and the danger of trusting labels and marketing in the absence of strong state protection. They may leave the impression that risks extend beyond this single product to a pattern of unsafe offerings in the market. Government-aligned coverage, while also warning of health risks such as gastrointestinal problems or hypoglycemia, tends to situate those risks within Invima's specific alert and reassurances that following official advice (immediately stopping use and consulting health professionals if needed) effectively mitigates the danger.

Political implications. Opposition-aligned media more readily connect the episode to a narrative of mismanagement, arguing that the presence of a fraudulent children's supplement on the market reflects broader governance and oversight failures. They may use the story to call for reforms or stronger accountability mechanisms. Government-aligned outlets largely depoliticize the event, treating it as a technical, health-focused issue and avoiding direct criticism of current authorities, instead emphasizing citizen cooperation with Invima's recommendations as the central takeaway.

In summary, opposition coverage tends to treat the Hansure Kids alert as a symptom of regulatory weakness and a broader pattern of institutional failure, while government-aligned coverage tends to present it as a demonstration of Invima’s active surveillance and a mostly technical public-health issue that is being properly managed.